William Gillanders, MD, a physician-scientist and avid cyclist, keeps the wheels turning in the race against breast cancer. His career goal is to change treatment paradigms by making breast cancer vaccines a reality for those being treated for the disease.
A breast cancer vaccine developed at the School of Medicine is safe in patients with metastatic breast cancer, results of an early clinical trial indicate. Preliminary evidence from the small clinical trial, led by William Gillanders, MD, also suggests that the vaccine primed the patients’ immune systems to attack tumor cells and helped slow the cancer’s progression.
An interdisciplinary group of graduate students including Washington University’s (from left) Anurag Agarwal, Whitney Grither and Hirak Biswas was one of 10 winning teams in the Breast Cancer Startup Challenge. The international competition aimed to bring breast cancer discoveries out of the lab and closer to market to help patients.